STOCK TITAN

Insmed To Present at Three November Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM) has announced its participation in three investor conferences in November 2022. The events include:

  • Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 2:35 PM ET in Rancho Palos Verdes, CA.
  • Stifel 2022 Healthcare Conference on November 15, 2022, at 2:25 PM ET in New York, NY.
  • Evercore ISI 5th Annual HealthCONx Virtual Conference on November 30, 2022, at 8:50 AM ET.
Live webcasts will be available on Insmed's investor relations website, with archives accessible for 30 days post-event.

Positive
  • None.
Negative
  • None.

BRIDGEWATER, N.J., Nov. 1, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:

  • The Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 8, 2022, at 2:35 PM ET in a fireside chat
  • The Stifel 2022 Healthcare Conference in New York, NY, on Tuesday, November 15, 2022, at 2:25 PM ET in a fireside chat
  • The Evercore ISI 5th Annual HealthCONx Virtual Conference on Wednesday, November 30, 2022, at 8:50 AM ET in a fireside chat

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of each live event.

About Insmed 
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser 
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey  
Executive Director, Corporate Communications 
Insmed 
(732) 718-3621
amanda.fahey@insmed.com

(PRNewsfoto/Insmed Incorporated)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-three-november-conferences-301663554.html

SOURCE Insmed Incorporated

FAQ

What is Insmed's stock symbol?

Insmed's stock symbol is INSM.

When is Insmed presenting at the Credit Suisse conference?

Insmed will present at the Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 2:35 PM ET.

Where will the Stifel 2022 Healthcare Conference be held?

The Stifel 2022 Healthcare Conference will be held in New York, NY on November 15, 2022.

What is the date of the Evercore ISI HealthCONx Virtual Conference?

The Evercore ISI 5th Annual HealthCONx Virtual Conference will take place on November 30, 2022, at 8:50 AM ET.

How can I access the live webcasts of Insmed's presentations?

The live webcasts of Insmed's presentations can be accessed through the investor relations section of their website.

Insmed, Inc.

NASDAQ:INSM

INSM Rankings

INSM Latest News

INSM Stock Data

12.06B
178.90M
0.91%
108.31%
7.66%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRIDGEWATER